![]() |
市場調查報告書
商品編碼
1492261
血管鏡設備市場:可用性,按最終用戶分類 - 2024-2030 年全球預測Angioscope Device Market by Usability (Disposable Angioscopes, Reusable Angioscopes), End User (Diagnostic Centers, Hospitals, Research & Academic Institutes) - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
血管鏡設備市場規模預估2023年為2.5158億美元,2024年達2.6677億美元,預計2030年將達到3.912億美元,複合年成長率為6.50%。
血管鏡設備市場包括專為血管鏡檢查而設計的醫療設備,血管鏡檢查是一種允許醫療專業人員透過配備光源和攝影機的小型軟性管可視化血管和器官內部的手術,稱為醫療設備。周邊動脈疾病和冠狀動脈疾病等疾病的增加刺激了對診斷和治療程序(包括血管鏡檢查)的需求。血管鏡設備的創新,包括增強的成像功能和方便用戶使用的介面,正在提高其功能和有效性,並吸引更多的醫療保健提供者。由於微創手術相對於傳統開放性手術的優勢,患者和醫生對微創手術的日益偏好也推動了市場的擴張。然而,醫療設備核准的嚴格監管要求可能會減緩新創新的市場進入並限制市場範圍。確保複雜血管鏡系統的品質和可靠性需要大量的專業知識和培訓,這給醫療保健專業人員帶來了挑戰。此外,將血管鏡設備與人工智慧等數位工具相結合可以實現更好的影像分析和病患監測,從而為市場成長開闢新的途徑。對緊湊型穿戴式血管鏡技術的持續研究可能會徹底改變門診病人護理和遠端監控,從而在未來幾年創造市場擴張機會。
主要市場統計 | |
---|---|
基準年[2023] | 25158萬美元 |
預測年份 [2024] | 2.6677 億美元 |
預測年份 [2030] | 3.912 億美元 |
複合年成長率(%) | 6.50% |
區域洞察
在美洲,特別是在美國和加拿大,由於人口老化和心血管疾病的嚴重流行,對先進醫療技術的需求很高。高額醫療支出和有利的報銷政策進一步推動了這些技術在美洲地區的採用。在歐盟國家,人們強烈渴望得到發達的公共醫療體系和健康保險支持的高品質治療。歐洲嚴格的法規環境確保市場上只有最可靠、最有效的醫療設備,其中德國、法國和英國在醫療設備使用方面處於領先地位。中東和非洲地區的情況好壞參半,沙烏地阿拉伯和阿拉伯聯合大公國等波灣合作理事會(GCC)國家增加了對醫療技術(包括血管鏡設備)的投資。亞太地區是血管鏡市場成長最快的地區,醫療基礎設施的增加、醫療旅遊業的增加以及健康意識的提高等因素促進了該地區的市場成長。日本因其先進的醫療保健技術和對醫學研究的大量投資而成為重要市場。中國和印度是新興市場,由於醫療保健政策的改善和不斷成長的中階尋求更好的醫療保健,採用率正在增加。
FPNV定位矩陣
FPNV 定位矩陣對於評估血管鏡設備市場供應商的市場定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對血管鏡設備市場供應商的當前狀態進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭力的寶貴見解,包括研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在血管鏡設備市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[183 Pages Report] The Angioscope Device Market size was estimated at USD 251.58 million in 2023 and expected to reach USD 266.77 million in 2024, at a CAGR 6.50% to reach USD 391.20 million by 2030.
The angioscope device market includes an arena of medical devices designed for angioscopy, a procedure that allows healthcare professionals to visualize the interior of blood vessels and organs through a small, flexible tube equipped with a light source and camera known as an angioscope. An increase in conditions such as peripheral artery disease and coronary artery disease fuels the demand for diagnostic and therapeutic procedures involving angioscopy. Innovations in angioscope devices, including enhanced imaging capabilities and user-friendly interfaces, have improved their functionality and effectiveness, attracting more healthcare providers. Rising preference for minimally invasive surgeries among patients and doctors alike for their benefits over traditional open surgeries supports market expansion. However, stringent regulatory requirements for approval of medical devices can delay market entry for new innovations, limiting the market scope. Ensuring the quality and reliability of intricate angioscope systems demands significant expertise and training, posing challenges for healthcare providers. Moreover, coupling angioscope devices with digital tools such as AI for better imaging analysis and patient monitoring may offer new avenues for growth in the market. Ongoing research into compact, wearable angioscope technology could revolutionize outpatient care and remote monitoring, generating opportunities for market expansion in upcoming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 251.58 million |
Estimated Year [2024] | USD 266.77 million |
Forecast Year [2030] | USD 391.20 million |
CAGR (%) | 6.50% |
Regional Insights
In the Americas, particularly in the United States and Canada, there is a high demand for advanced medical technologies due to an aging population and a significant prevalence of cardiovascular diseases. High healthcare expenditure and favorable reimbursement policies further support adopting these technologies in the Americas region. European Union countries strongly prefer high-standard medical treatments supported by extensive public healthcare systems and health insurance coverage. Europe's stringent regulatory environment ensures that only the most reliable and effective devices are available in the market, with Germany, France, and the UK leading in medical device usage. The Middle East and Africa region presents a mixed scenario where the Gulf Cooperation Council (GCC) countries such as Saudi Arabia and the UAE show increasing investment in health technology, including angioscope devices. Asia Pacific is a rapidly growing region in the market for angioscope devices, and factors such as increasing healthcare infrastructure, rising medical tourism, and growing health awareness are contributing to the market growth in the region. Japan stands out as a significant market with advanced healthcare technologies and substantial investment in medical research. China and India are emerging markets with increasing adoption rates due to improving healthcare policies and the rise of middle-class populations demanding better medical care.
Market Insights
The market dynamics represent an ever-changing landscape of the Angioscope Device Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Angioscope Device Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Angioscope Device Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Abbott's Introduction of AI-Enhanced Vascular Imaging in India, Revolutionizing Cardiac Care
Abbott Laboratories has introduced a cutting-edge vascular imaging platform in India, which is enhanced by Ultreon 1.0 Software. The advanced system integrates optical coherence tomography (OCT) with artificial intelligence (AI) to provide doctors with a detailed view of blood flow and vessel blockages, enabling precise measurements of vessel diameters. The newly launched technology substantially improves the accuracy of stent deployment during coronary procedures by offering real-time, high-definition imagery from within the blood vessels. [Published On: 2023-10-17]
Canon Medical Launches Alphenix Evolve Edition Angiography System in European Market
Canon Medical Systems Corporation has launched the Alphenix / Evolve Edition angiography system, designed to support percutaneous coronary intervention (PCI) and structural heart disease procedures by utilizing deep learning technology for enhanced imaging and reduced operational times and radiation doses. The system is a part of Canon Medical's aEvolve portfolio, which integrates AI-driven technologies to aid real-time diagnostic and therapeutic decision-making processes seamlessly within existing workflows. [Published On: 2023-08-07]
Abbott Acquires Cardiovascular Systems, Inc. to Enhance Vascular Treatment Technologies
Abbott Laboratories has entered into a definitive agreement to acquire Cardiovascular Systems, Inc. (CSI), a pioneer in the development of atherectomy systems for the treatment of arterial diseases, for approximately USD 890 million. The acquisition is set to enrich Abbott's portfolio with cutting-edge vascular technologies and an experienced team, reinforcing its position in the vascular intervention market. [Published On: 2023-02-08]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Angioscope Device Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Angioscope Device Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Boston Scientific Corporation, Canon Medical Systems, Cardinal Health, Cook Medical, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Johnson & Johnson Services, Inc., Karl Storz, LivaNova PLC, Medtronic PLC, Olympus Corporation, Philips Healthcare, Shimadzu Corporation, Siemens Healthineers, Smith & Nephew PLC, Stryker Corporation, Terumo Corporation, Vena Medica, and Zimmer Biomet.
Market Segmentation & Coverage